These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 20029235

  • 21. [Effect of estrogen therapy on the growth of Turner syndrome in girls treated with growth hormone].
    Morin A, Guimarey L, Apezteguia M, Santucci Z.
    Medicina (B Aires); 2001; 61(3):271-4. PubMed ID: 11474872
    [Abstract] [Full Text] [Related]

  • 22. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
    Binder G, Trebar B, Baur F, Schweizer R, Ranke MB.
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
    [Abstract] [Full Text] [Related]

  • 23. Impact of Growth Hormone Therapy on Adult Height in Patients with PTPN11 Mutations Related to Noonan Syndrome.
    Malaquias AC, Noronha RM, Souza TTO, Homma TK, Funari MFA, Yamamoto GL, Silva FV, Moraes MB, Honjo RS, Kim CA, Nesi-França S, Carvalho JAR, Quedas EPS, Bertola DR, Jorge AAL.
    Horm Res Paediatr; 2019 Apr; 91(4):252-261. PubMed ID: 31132774
    [Abstract] [Full Text] [Related]

  • 24. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.
    J Pediatr Endocrinol Metab; 2001 Apr; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF.
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [Abstract] [Full Text] [Related]

  • 27. The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age.
    Kappelgaard AM, Laursen T.
    Growth Horm IGF Res; 2011 Dec; 21(6):305-13. PubMed ID: 22019012
    [Abstract] [Full Text] [Related]

  • 28. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [Abstract] [Full Text] [Related]

  • 29. Long-term growth hormone therapy in an adolescent boy with 45,X/46,XidicY(p11).
    Guevarra FM, Nimkarn S, New MI, Lin-Su K.
    J Pediatr; 2009 Nov; 155(5):752-5.e1-3. PubMed ID: 19840619
    [Abstract] [Full Text] [Related]

  • 30. Noonan syndrome, the Ras-MAPK signalling pathway and short stature.
    Binder G.
    Horm Res; 2009 Apr; 71 Suppl 2():64-70. PubMed ID: 19407499
    [Abstract] [Full Text] [Related]

  • 31. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.
    Stagi S, Ferrari V, Ferrari M, Priolo M, Tartaglia M.
    Front Endocrinol (Lausanne); 2022 May; 13():951331. PubMed ID: 36060964
    [Abstract] [Full Text] [Related]

  • 35. GH Therapy and first final height data in Noonan-like syndrome with loose anagen hair (Mazzanti syndrome).
    Mazzanti L, Tamburrino F, Scarano E, Perri A, Vestrucci B, Guidetti M, Rossi C, Tartaglia M.
    Am J Med Genet A; 2013 Nov; 161A(11):2756-61. PubMed ID: 24124081
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy.
    McWilliams GD, SantaCruz K, Hart B, Clericuzio C.
    Am J Med Genet A; 2016 Jan; 170A(1):195-201. PubMed ID: 26377682
    [Abstract] [Full Text] [Related]

  • 38. Short stature and its treatment in Turner and Noonan syndromes.
    Chacko EM, Rapaport R.
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):40-6. PubMed ID: 22157403
    [Abstract] [Full Text] [Related]

  • 39. Growth and Growth Hormone Treatment in Noonan Syndrome.
    Romano AA.
    Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):459-464. PubMed ID: 31115197
    [Abstract] [Full Text] [Related]

  • 40. Treatment with Growth Hormone in Noonan Syndrome Observed during 25 Years of KIGS: Near Adult Height and Outcome Prediction.
    Ranke MB, Lindberg A, Carlsson M, Camacho-Hübner C, Rooman R.
    Horm Res Paediatr; 2019 May; 91(1):46-55. PubMed ID: 30939478
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.